Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. nature reviews immunology 
3. review articles 
4. article
•  Review Article
•  Published: 01 May 2005


Mechanisms of type-I- and
type-II-interferon-mediated
signalling
•  Leonidas C. Platanias1 
Nature Reviews Immunology volume 5, pages 375–386 (2005)Cite
this article
•  183k Accesses
•  3047 Citations
•  29 Altmetric
•  Metrics details
Key Points
•  There are two main classes of interferon (IFN): type I IFNs
and type II IFN. There are many type I IFNs, including IFN-α,
IFN-β and IFN-ω, and all of these bind a common cell-surface
receptor. IFN-γ, the only type II IFN, initiates signalling by
binding a distinct receptor at the cell surface.
•  Type I and type II IFNs activate both common and distinct
STAT (signal transducer and activator of transcription)
complexes, which regulate the transcription of target genes.
•  In addition to the classical Janus activated kinase (JAK)–
STAT-signalling pathways, both type I and type II IFNs
activate several other signalling cascades.
•  CRKL, a member of the CRK family of proteins, is activated
by both type I and type II IFNs, and it functions as a nuclear
adaptor for STAT5 and/or as an upstream regulator of a
signalling pathway that involves the guanine-nucleotide-


exchange factor C3G and RAP1.
•  The mitogen-activated protein kinase p38 is activated by type
I IFNs and has a crucial role in the type-I-IFN-dependent
transcription of genes and in the generation of the
antiproliferative and antiviral effects of type I IFNs.
•  Both type I and type II IFNs regulate activation of the
phosphatidylinositol 3-kinase (PI3K)-signalling pathway. One
of the downstream effectors of PI3K is protein kinase C-δ,
which functions as a serine kinase for STAT1.
•  At least two distinct pathways for the regulation of mRNA
translation are activated downstream of IFN-activated PI3K
and mammalian target of rapamycin (MTOR). One involves
activation of p70 S6 kinase and phosphorylation of ribosomal
protein S6, and the other involves phosphorylation and
deactivation of the translational repressor 4EBP1 (eukaryotic
translation-initiation factor 4E (EIF4E)-binding protein 1).
Abstract
Interferons are cytokines that have antiviral, antiproliferative and
immunomodulatory effects. Because of these important properties,
in the past two decades, major research efforts have been
undertaken to understand the signalling mechanisms through which
these cytokines induce their effects. Since the original discovery of
the classical JAK (Janus activated kinase)–STAT (signal transducer
and activator of transcription) pathway of signalling, it has become
clear that the coordination and cooperation of multiple distinct
signalling cascades — including the mitogen-activated protein
kinase p38 cascade and the phosphatidylinositol 3-kinase cascade
— are required for the generation of responses to interferons. It is
anticipated that an increased understanding of the contributions of
these recently identified pathways will advance our current
thinking about how interferons work.
 Access through your institution
Buy or subscribe


This is a preview of subscription content, access via your institution
Access options
 Access through your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Learn more
Buy this article
•  Purchase on SpringerLink
•  Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during
checkout
Additional access options:
•  Log in
•  Learn about institutional subscriptions
•  Read our FAQs
•  Contact customer support
Figure 1: Interferon receptors and activation of classical JAK–
STAT pathways by type I and type II interferons.
[image]
Figure 2: Activation of CRKL during engagement of the type I
interferon receptor, and the role of CRKL in type-I-interferon-
mediated signalling.
[image]


Figure 3: Mechanisms of activation of the mitogen-activated
protein kinase p38 and its downstream effectors by type I
interferons.
[image]
Figure 4: Activation of phosphatidylinositol 3-kinase and
protein kinase C-δ by the type II interferon receptor and
crosstalk with the STAT-signalling pathway.
[image]
Figure 5: Type-I-interferon-activated signalling pathways that
mediate initiation of mRNA translation.
[image]
Similar content being viewed by others
[image]
Evolving cognition of the JAK-STAT signaling
pathway: autoimmune disorders and cancer
Article Open access 19 May 2023
[image]
Proximal protein landscapes of the type I interferon
signaling cascade reveal negative regulation by PJA2
Article Open access 27 May 2024
[image]
Computer aided designing of novel pyrrolopyridine
derivatives as JAK1 inhibitors
Article Open access 29 November 2021
References
1. Pestka, S., Langer, J. A., Zoon, K. C. & Samuel, C. E.
Interferons and their actions. Annu. Rev. Biochem. 56, 727–
777 (1987).


Article  CAS  PubMed  Google Scholar 
2. Pestka, S., Krause, C. D. & Walter, M. R. Interferons,
interferon-like cytokines, and their receptors. Immunol. Rev.
202, 8–32 (2004).
Article  CAS  PubMed  Google Scholar 
3. Pestka, S. The human interferon α species and hybrid
proteins. Semin. Oncol. 24, S9-4–S9-17 (1997).
Google Scholar 
4. Chen, J., Baig, E. & Fish, E. N. Diversity and relatedness
among the type I interferons. J. Interfon Cytokine Res. 24,
687–698 (2004).
Article  CAS  Google Scholar 
5. Platanias, L. C. & Fish, E. N. Signaling pathways activated by
interferons. Exp. Hematol. 27, 1583–1592 (1999).
Article  CAS  PubMed  Google Scholar 
6. Parmar, S. & Platanias, L. C. Interferons: mechanisms of
action and clinical applications. Curr. Opin. Oncol. 15, 431–
439 (2003).
Article  CAS  PubMed  Google Scholar 
7. Pestka, S. et al. The interferon γ (IFN-γ) receptor: a paradigm
for the multichain cytokine receptor. Cytokine Growth Factor
Rev. 8, 189–206 (1997).
Article  CAS  PubMed  Google Scholar 
8. Bach, E. A., Aguet, M. & Schreiber, R. D. The IFN γ receptor:
a paradigm for cytokine receptor signaling. Annu. Rev.
Immunol. 15, 563–591 (1997).
Article  CAS  PubMed  Google Scholar 


9. Isaacs, A. & Lindenmann, J. Virus interference. I. The
interferon. Proc. R. Soc. Lond. B 147, 258–267 (1957).
Article  CAS  PubMed  Google Scholar 
10. Kotenko, S. V. et al. IFN-λs mediate antiviral protection
through a distinct class II cytokine receptor complex. Nature
Immunol. 4, 69–77 (2003).
Article  CAS  Google Scholar 
11. Darnell, J. E., Kerr, I. M. & Stark, G. R. Jak–STAT pathways
and transcriptional activation in response to IFNs and other
extracellular proteins. Science 264, 1415–1420 (1994). A
comprehensive review of the IFN-activated JAK–STAT-
signalling pathways.
Article  CAS  PubMed  Google Scholar 
12. Ihle, J. N. The Janus protein tyrosine kinase family and its
role in cytokine signaling. Adv. Immunol. 60, 1–35 (1995).
Article  CAS  PubMed  Google Scholar 
13. Platanias, L. C. The p38 mitogen-activated protein kinase
pathway and its role in interferon signaling. Pharmacol. Ther.
98, 129–142 (2003).
Article  CAS  PubMed  Google Scholar 
14. Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H.
Identification of genes differentially regulated by interferon
α, β, or γ using oligonucleotide arrays. Proc. Natl Acad. Sci.
USA 95, 15623–15628 (1998).
Article  CAS  PubMed  PubMed Central  Google Scholar 
15. Schindler, C., Shuai, K., Prezioso, V. R. & Darnell, J. E.
Interferon-dependent tyrosine phosphorylation of a latent
cytoplasmic transcription factor. Science 257, 809–813
(1992).


Article  CAS  PubMed  Google Scholar 
16. Fu, X. Y., Schindler, C., Improta, T., Aebersold, R. & Darnell,
J. E. The proteins of ISGF-3, the interferon α-induced
transcriptional activator, define a gene family involved in
signal transduction. Proc. Natl Acad. Sci. USA 89, 7840–7843
(1992).
Article  CAS  PubMed  PubMed Central  Google Scholar 
17. Shuai, K., Schindler, C., Prezioso, V. R. & Darnell, J. E.
Activation of transcription by IFN-γ: tyrosine phosphorylation
of a 91-kD DNA binding protein. Science 258, 1808–1812
(1992).
Article  CAS  PubMed  Google Scholar 
18. Silvennoinen, O., Ihle, J. N., Schlessinger, J. & Levy, D. E.
Interferon-induced nuclear signaling by Jak protein tyrosine
kinases. Nature 366, 583–585 (1993).
Article  CAS  PubMed  Google Scholar 
19. Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H. &
Schreiber, R. D. How cells respond to interferons. Annu. Rev.
Biochem. 67, 227–264 (1998).
Article  CAS  PubMed  Google Scholar 
20. Darnell, J. E. Stats and gene regulation. Science 277, 1630–
1635 (1997). An excellent review of the mechanisms of
STAT activation and the regulatory effects of STATs on
gene transcription.
Article  CAS  PubMed  Google Scholar 
21. Aaronson, D. S. & Horvath C. M. A road map for those who
don't know JAK–STAT. Science 296, 1653–1655 (2002).
Article  CAS  PubMed  Google Scholar 
22. Meinke, A., Barahmand-Pour, F., Wohrl, S., Stoiber, D. &


Decker, T. Activation of different Stat5 isoforms contributes
to cell-type-restricted signaling in response to interferons.
Mol. Cell. Biol. 16, 6937–6944 (1996).
Article  CAS  PubMed  PubMed Central  Google Scholar 
23. Farrar, J. D., Smith, J. D., Murphy, T. L. & Murphy, K. M.
Recruitment of Stat4 to the human interferon-α/β receptor
requires activated Stat2. J. Biol. Chem. 275, 2693–2697
(2000).
Article  CAS  PubMed  Google Scholar 
24. Torpey, N., Maher, S. E., Bothwell, A. L. & Pober, J. S.
Interferon α but not interleukin 12 activates STAT4 signaling
in human vascular endothelial cells. J. Biol. Chem. 279,
26789–26796 (2004).
Article  CAS  PubMed  Google Scholar 
25. Matikainen, S. et al. Interferon-α activates multiple STAT
proteins and upregulates proliferation-associated IL-2Rα, c-
myc, and pim-1 genes in human T cells. Blood 93, 1980–1991
(1999).
Article  CAS  PubMed  Google Scholar 
26. Fasler-Kan, E., Pansky, A., Wiederkehr, M., Battegay, M. &
Heim, M. H. Interferon-α activates signal transducers and
activators of transcription 5 and 6 in Daudi cells. Eur. J.
Biochem. 254, 514–519 (1998).
Article  CAS  PubMed  Google Scholar 
27. Nguyen, K. B. et al. Critical role for STAT4 activation by type
1 interferons in the interferon-γ response to viral infection.
Science 297, 2063–2066 (2002).
Article  CAS  PubMed  Google Scholar 
28. Boehm, U., Klamp, T., Groot, M. & Howard, J. C. Cellular
responses to interferon-γ. Annu. Rev. Immunol. 15, 749–795


(1997).
Article  CAS  PubMed  Google Scholar 
29. Wen, Z., Zhong, Z. & Darnell, J. E. Maximal activation of
transcription by Stat1 and Stat3 requires both tyrosine and
serine phosphorylation. Cell 82, 241–250 (1995).
Article  CAS  PubMed  Google Scholar 
30. Wen, Z. & Darnell, J. E. Mapping of Stat3 serine
phosphorylation to a single residue (727) and evidence that
serine phosphorylation has no influence on DNA binding of
Stat1 and Stat3. Nucleic Acids Res. 25, 2062–2067 (1997).
Article  CAS  PubMed  PubMed Central  Google Scholar 
31. Varinou, L. et al. Phosphorylation of the Stat1 transactivation
domain is required for full-fledged IFN-γ-dependent innate
immunity. Immunity 19, 793–802 (2003).
Article  CAS  PubMed  Google Scholar 
32. Uddin, S. et al. Protein kinase C-δ (PKC-δ) is activated by type
I interferons and mediates phosphorylation of Stat1 on serine
727. J. Biol. Chem. 277, 14408–14416 (2002). The first
identification of PKC-δ as an IFN-activated kinase that
regulates the phosphorylation of STAT1 on Ser727.
Article  CAS  PubMed  Google Scholar 
33. Deb, D. K. et al. Activation of protein kinase C δ by IFN-γ. J.
Immunol. 171, 267–273 (2003).
Article  CAS  PubMed  Google Scholar 
34. Kristof, A. S., Marks-Konczalik, J., Billings, E. & Moss, J.
Stimulation of signal transducer and activator of
transcription-1 (STAT1)-dependent gene transcription by
lipopolysaccharide and interferon-γ is regulated by
mammalian target of rapamycin. J. Biol. Chem. 278, 33637–
33644 (2003).


Article  CAS  PubMed  Google Scholar 
35. Choudhury, G. G. A linear signal transduction pathway
involving phosphatidylinositol 3-kinase, protein kinase C-ε,
and MAPK in mesangial cells regulates interferon-γ-induced
STAT1α transcriptional activation. J. Biol. Chem. 279, 27399–
27409 (2004).
Article  CAS  PubMed  Google Scholar 
36. Nair, J. S. et al. Requirement of Ca2+ and CaMKII for Stat1
Ser-727 phosphorylation in response to IFN-γ. Proc. Natl
Acad. Sci. USA 99, 5971–5976 (2002).
Article  CAS  PubMed  PubMed Central  Google Scholar 
37. Zhang, J. J. et al. Two contact regions between Stat1 and
CBP/p300 in interferon γ signaling. Proc. Natl Acad. Sci. USA
93, 15092–15096 (1996).
Article  CAS  PubMed  PubMed Central  Google Scholar 
38. Bhattacharya, S. et al. Cooperation of Stat2 and p300/CBP in
signaling induced by interferon-α. Nature 383, 344–347
(1996).
Article  CAS  PubMed  Google Scholar 
39. Zhang, J. J. et al. Ser727-dependent recruitment of MCM5 by
Stat1α in IFN-γ-induced transcriptional activation. EMBO J.
17, 6963–6971 (1998).
Article  CAS  PubMed  PubMed Central  Google Scholar 
40. DaFonseca, C. J., Shu, F. & Zhang, J. J. Identification of two
residues in MCM5 critical for the assembly of MCM
complexes and Stat1-mediated transcription activation in
response to IFN-γ. Proc. Natl Acad. Sci. USA 98, 3034–3039
(2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 


41. Hebbes, T. R., Thorne, A. W. & Crane-Robinson, C. A direct
link between core histone acetylation and transcriptionally
active chromatin. EMBO J. 7, 1395–1402 (1988).
Article  CAS  PubMed  PubMed Central  Google Scholar 
42. Paulson, M., Press, C., Smith, E., Tanese, E. & Levy, D. E. IFN-
stimulated transcription through a TBP- free acetyltransferase
complex escapes viral shutoff. Nature Cell Biol. 4, 140–147
(2002).
Article  CAS  PubMed  Google Scholar 
43. Huang, M. et al. Chromatin-remodelling factor BRG1
selectively activates a subset of interferon-α-inducible genes.
Nature Cell Biol. 4, 774–781 (2002).
Article  CAS  PubMed  Google Scholar 
44. Zhu, M., John, S., Berg, M. & Leonard, W. J. Functional
association of Nmi with Stat5 and Stat1 in IL-2- and IFNγ-
mediated signaling. Cell 96, 121–130 (1999).
Article  CAS  PubMed  Google Scholar 
45. Nusinzon, I. & Horvath, C. M. Interferon-stimulated
transcription and innate antiviral immunity require
deacetylase activity and histone deacetylase 1. Proc. Natl
Acad. Sci. USA 100, 14742–14747 (2003). The first evidence
that histone-deacetylase activity is required for IFN-
dependent transcription.
Article  CAS  PubMed  PubMed Central  Google Scholar 
46. Chang, H. M. et al. Induction of interferon-stimulated gene
expression and antiviral responses require protein deacetylase
activity. Proc. Natl Acad. Sci. USA 101, 9578–9583 (2004).
Article  CAS  PubMed  PubMed Central  Google Scholar 
47. Sakamoto, S., Potla, R. & Larner, A. C. Histone deacetylase
activity is required to recruit RNA polymerase II to the


promoters of selected interferon-stimulated early response
genes. J. Biol. Chem. 279, 40362–40367 (2004).
Article  CAS  PubMed  Google Scholar 
48. Mayer, B. J., Hamaguchi, M. & Hanafusa, H. A novel viral
oncogene with structural homology to phospholipase C.
Nature 332, 272–275 (1988).
Article  CAS  PubMed  Google Scholar 
49. Feller, S. M. Crk family adaptors — signaling complex
formation and biological roles. Oncogene 20, 6348–6371
(2001).
Article  CAS  PubMed  Google Scholar 
50. Ahmad, S., Alsayed, Y., Druker, B. J. & Platanias, L. C. The
type I interferon receptor mediates tyrosine phosphorylation
of the CrkL adaptor protein. J. Biol. Chem. 272, 29991–29994
(1997).
Article  CAS  PubMed  Google Scholar 
51. Alsayed, Y. et al. Interferon-γ activates the C3G/Rap1
signaling pathway. J. Immunol. 164, 1800–1806 (2000).
Article  CAS  PubMed  Google Scholar 
52. Stork, P. J. Does Rap1 deserve a bad Rap? Trends Biochem.
Sci. 28, 267–275 (2003).
Article  CAS  PubMed  Google Scholar 
53. Bos, J. L., de Rooij, J. & Reedquist, K. A. Rap1 signaling:
adhering to new models. Nature Rev. Mol. Cell Biol. 2, 369–
377 (2001).
Article  CAS  Google Scholar 
54. Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. & Noda,
M. A ras-related gene with transformation suppressor activity.


Cell 56, 77–84 (1989).
Article  CAS  PubMed  Google Scholar 
55. Schmitt, J. M. & Stork, P. J. Cyclic AMP-mediated inhibition
of cell growth requires the small G protein Rap1. Mol. Cell.
Biol. 21, 3671–3683 (2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
56. Lahlou, H. et al. sst2 Somatostatin receptor inhibits cell
proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2
activation. J. Biol. Chem. 278, 39356–39371 (2003).
Article  CAS  PubMed  Google Scholar 
57. Hattori, M. & Minato, N. Rap1 GTPase: functions, regulation
and malignancy. J. Biochem. 134, 479–484 (2003).
Article  CAS  PubMed  Google Scholar 
58. Lekmine, F. et al. The CrkL adapter protein is required for
type I interferon-dependent gene transcription and activation
of the small G-protein Rap1. Biochem. Biophys. Res. Commun.
291, 744–750 (2002).
Article  CAS  PubMed  Google Scholar 
59. Platanias, L. C. et al. CrkL and CrkII participate in the
generation of the growth inhibitory effects of interferons on
primary hematopoietic progenitors. Exp. Hematol. 27, 1315–
1321 (1999).
Article  CAS  PubMed  Google Scholar 
60. Huang, C. C., You, J. L., Wu, M. Y. & Hsu, K. S. Rap1-induced
p38 mitogen-activated protein kinase activation facilitates
AMPA receptor trafficking via the GDI•Rab5 complex.
Potential role in (S)-3,5-dihydroxyphenylglycene-induced
long-term depression. J. Biol. Chem. 279, 12286–12292
(2004).


Article  CAS  PubMed  Google Scholar 
61. Katagiri, K. et al. Crucial functions of the Rap1 effector
molecule RAPL in lymphocyte and dendritic cell trafficking.
Nature Immunol. 5, 1045–1051 (2004).
Article  CAS  Google Scholar 
62. Fish, E. N. et al. Activation of a CrkL–Stat5 signaling complex
by type I interferons. J. Biol. Chem. 274, 571–573 (1999). The
first report that CRKL forms DNA-binding complexes with
STAT5 and functions as a nuclear adaptor for STAT5 in
type-I-IFN-mediated signalling.
Article  CAS  PubMed  Google Scholar 
63. Grumbach, I. M. et al. Engagement of the CrkL adapter in
interferon α signaling in BCR–ABL expressing cells. Br. J.
Haematol. 112, 327–336 (2001).
Article  CAS  PubMed  Google Scholar 
64. Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J. & de The,
H. PML nuclear bodies and apoptosis. Oncogene 23, 2819–
2824 (2004).
Article  CAS  PubMed  Google Scholar 
65. Uddin, S. et al. Role of Stat5 in type I interferon-signaling and
transcriptional regulation. Biochem. Biophys. Res. Commun.
308, 325–330 (2003).
Article  CAS  PubMed  Google Scholar 
66. Schaeffer, H. J. & Weber, M. J. Mitogen-activated protein
kinases: specific messages from ubiquitous messengers. Mol.
Cell. Biol. 19, 2435–2444 (1999).
Article  CAS  PubMed  PubMed Central  Google Scholar 
67. Chang, L. & Karin, M. Mammalian MAP kinase signaling
cascades. Nature 410, 37–40 (2001).


Article  CAS  PubMed  Google Scholar 
68. Dong, C., Davis, R. J. & Flavell, R. A. MAP kinases in the
immune response. Annu. Rev. Immunol. 20, 55–72 (2002).
Article  CAS  PubMed  Google Scholar 
69. Hazzalin, C. A. & Mahadevan, L. C. MAPK-regulated
transcription: a continuously variable gene switch? Nature
Rev. Mol. Cell Biol. 3, 30–40 (2002).
Article  CAS  Google Scholar 
70. Platanias, L. C. Map kinase signaling pathways and
hematologic malignancies. Blood 101, 4667–4679 (2003).
Article  CAS  PubMed  Google Scholar 
71. Uddin, S. et al. Activation of the p38 Map kinase by type I
interferons. J. Biol. Chem. 274, 30127–30131 (1999).
Article  CAS  PubMed  Google Scholar 
72. Goh, K. C., Haque, S. J. & Williams, B. R. p38 MAP kinase is
required for STAT1 serine phosphorylation and
transcriptional activation induced by interferons. EMBO J. 18,
5601–5608 (1999).
Article  CAS  PubMed  PubMed Central  Google Scholar 
73. Uddin, S. et al. The Rac1/p38 Map kinase pathway is
required for IFNα-dependent transcriptional activation but
not serine phosphorylation of Stat-proteins. J. Biol. Chem.
275, 27634–27640 (2000).
Article  CAS  PubMed  Google Scholar 
74. Kovarik, P. et al. Stress-induced phosphorylation of Stat1 at
Ser727 requires p38 mitogen-activated protein kinase
whereas IFN-γ uses a different pathway. Proc. Natl Acad. Sci.
USA 96, 13956–13961 (1999).


Article  CAS  PubMed  PubMed Central  Google Scholar 
75. Li, Y. et al. Role of p38α Map kinase in type I interferon
signaling. J. Biol. Chem. 279, 970–979 (2004). Definitive
evidence that the type-I-IFN-activated p38-signalling
pathway is required for transcriptional regulation.
Article  CAS  PubMed  Google Scholar 
76. Ramsauer, K. et al. p38 MAPK enhances STAT1-dependent
transcription independently of Ser-727 phosphorylation. Proc.
Natl Acad. Sci. USA 99, 12859–12864 (2002).
Article  CAS  PubMed  PubMed Central  Google Scholar 
77. Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. &
Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1
GDP/GTP exchange by the vav proto-oncogene product.
Nature 385, 169–172 (1997).
Article  CAS  PubMed  Google Scholar 
78. Bustelo, X. R. Regulatory and signaling properties of the Vav
family. Mol. Cell. Biol. 20, 1461–1477 (2000).
Article  CAS  PubMed  PubMed Central  Google Scholar 
79. Platanias, L. C. & Sweet, M. E. Interferon α induces rapid
tyrosine phosphorylation of the vav proto-oncogene product
in hematopoietic cells. J. Biol. Chem. 269, 3143–3146 (1994).
Article  CAS  PubMed  Google Scholar 
80. Micouin, A., Wietzrbin, J., Steunou, V. & Martyre, M. C.
p95Vav is associated to the IFNα/β receptor and contributes
to the antiproliferative effect of IFNα in megacaryocytic cell
lines. Oncogene 19, 387–394 (2000).
Article  CAS  PubMed  Google Scholar 
81. Uddin, S., Sweet, M. E., Colamonici, O. R., Krolewski, J. J. &
Platanias, L. C. The vav proto-oncogene product interacts with


the Tyk-2 tyrosine kinase. FEBS Lett. 403, 31–34 (1997).
Article  CAS  PubMed  Google Scholar 
82. Li, Y. et al. Activation of Mkk3 and Mkk6 by type I
interferons. J. Biol. Chem. 280, 10001–10010 (2005).
Article  CAS  PubMed  Google Scholar 
83. Kotlyarov, A. & Gaestel, M. Is MK2 (mitogen-activated protein
kinase-activated protein kinase 2) the key for understanding
post-transcriptional regulation of gene expression? Biochem.
Soc. Trans. 30, 959–963 (2002).
Article  CAS  PubMed  Google Scholar 
84. Deak, M., Clifton A. D., Lucocq, L. M. & Alessi, D. R. Mitogen-
and stress-activated protein kinase-1 (MSK1) is directly
activated by MAPK and SAPK2/p38, and may mediate
activation of CREB. EMBO J. 17, 4426–4441 (1998).
Article  CAS  PubMed  PubMed Central  Google Scholar 
85. Soloaga, A. et al. MSK2 and MSK1 mediate the mitogen- and
stress-induced phosphorylation of histone H3 and HMG-14.
EMBO J. 22, 2788–2797 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
86. Clayton, A. L. & Mahadevan, L. C. MAP kinase-mediated
phosphoacetylation of histone H3 and inducible gene
regulation. FEBS Lett. 546, 51–58 (2003).
Article  CAS  PubMed  Google Scholar 
87. Waskiewicz, A. J., Flynn, A., Proud, C. G. & Cooper, J. A.
Mitogen-activated protein kinases activate the serine/
threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909–1920
(1997).
Article  CAS  PubMed  PubMed Central  Google Scholar 


88. Knauf, U., Tschopp, C. & Gram, H. Negative regulation of
protein translation by mitogen-activated protein kinase-
interacting kinases 1 and 2. Mol. Cell. Biol. 21, 5500–5511
(2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
89. Mayer, I. A. et al. The p38 MAPK pathway mediates the
growth inhibitory effects of interferon-α in BCR–ABL-
expressing cells. J. Biol. Chem. 276, 28570–28577 (2001).
Article  CAS  PubMed  Google Scholar 
90. Verma, A. et al. Activation of the p38 Map kinase pathway
mediates the suppressive effects of type I interferons and
transforming growth factor β on normal hematopoiesis. J.
Biol. Chem. 277, 7726–7735 (2002).
Article  CAS  PubMed  Google Scholar 
91. Ishida, H. et al. Involvement of p38 signaling pathway in
interferon-α-mediated antiviral activity towards hepatitis C
virus. Biochem. Biophys. Res. Commun. 321, 722–727 (2004).
Article  CAS  PubMed  Google Scholar 
92. Katze, M. G., He, Y. & Gale, M. Viruses and interferon: a fight
for supremacy. Nature Rev. Immunol. 2, 675–687 (2002). An
excellent review of the mechanisms by which IFNs
mediate antiviral effects.
Article  CAS  Google Scholar 
93. David, M. et al. Requirement for MAP kinase (ERK2) activity
in interferon α- and interferon β-stimulated gene expression
through STAT proteins. Science 269, 1721–1723 (1995).
Article  CAS  PubMed  Google Scholar 
94. Hu, J. et al. ERK1 and ERK2 activate CCAAAT/enhancer-
binding protein-β-dependent gene transcription in response to
interferon-γ. J. Biol. Chem. 276, 287–297 (2001).


Article  CAS  PubMed  Google Scholar 
95. Wang, F. et al. Disruption of Erk-dependent type I interferon
induction breaks the myxoma virus species barrier. Nature
Immunol. 5, 1266–1274 (2004).
Article  CAS  Google Scholar 
96. Roy, S. K. et al. MEKK1 plays a critical role in activating the
transcription factor C/EBP-β-dependent gene expression in
response to IFN-γ. Proc. Natl Acad. Sci. USA 99, 7945–7950
(2002).
Article  CAS  PubMed  PubMed Central  Google Scholar 
97. Roy, S. K., Wachira, S. J., Weihua, X., Hu, J. & Kalvakolanu,
D. V. CCAAT/enhancer-binding protein-β regulates
interferon-induced transcription through a novel element. J.
Biol. Chem. 275, 12626–12632 (2000).
Article  CAS  PubMed  Google Scholar 
98. Floyd, Z. E. & Stephens, J. M. Interferon-γ-mediated
activation and ubiquitin-proteasome-dependent degradation
of PPARγ in adipocytes. J. Biol. Chem. 277, 4062–4068
(2002).
Article  CAS  PubMed  Google Scholar 
99. Li, C. et al. IFNα induces Fas expression and apoptosis in
hedgehog pathway activated BCC cells through inhibiting
Ras–Erk signaling. Oncogene 23, 1608–1617 (2004).
Article  CAS  PubMed  Google Scholar 
100. Li, G., Xiang, Y., Sabapathy, K. & Silverman, R. H. An
apoptotic signaling pathway in the interferon antiviral
response mediated by RNase L and c-Jun NH2-terminal
kinase. J. Biol. Chem. 279, 1123–1131 (2004).
Article  CAS  PubMed  Google Scholar 


101. Uddin, S. et al. Interferon-α engages the insulin receptor
substrate-1 to associate with the phosphatidylinositol 3′-
kinase. J. Biol. Chem. 270, 15938–159341 (1995).
Article  CAS  PubMed  Google Scholar 
102. White, M. F. Insulin signaling in health and disease. Science
302, 1710–1711 (2003).
Article  CAS  PubMed  Google Scholar 
103. Platanias, L. C. et al. The type I interferon receptor mediates
tyrosine phosphorylation of insulin receptor substrate 2. J.
Biol. Chem. 271, 278–282 (1996).
Article  CAS  PubMed  Google Scholar 
104. Burfoot, M. S. et al. Janus kinase-dependent activation of
insulin receptor substrate 1 in response to interleukin-4,
oncostatin M, and the interferons. J. Biol. Chem. 272, 24183–
24190 (1997).
Article  CAS  PubMed  Google Scholar 
105. Uddin, S. et al. The IRS-pathway operates distinctively from
the Stat-pathway in hematopoietic cells and transduces
common and distinct signals during engagement of the insulin
or interferon-α receptors. Blood 90, 2574–2582 (1997).
CAS  PubMed  Google Scholar 
106. Uddin, S. et al. Interferon-dependent activation of the serine
kinase PI 3′-kinase requires engagement of the IRS pathway
but not the Stat pathway. Biochem. Biophys. Res. Commun.
270, 158–162 (2000).
Article  CAS  PubMed  Google Scholar 
107. Uddin, S. et al. Activation of the phosphatidylinositol 3-kinase
serine kinase by IFN-α. J. Immunol. 158, 2390–2397 (1997).
CAS  PubMed  Google Scholar 


108. Cengel, K. A. & Freund, G. G. JAK1-dependent
phosphorylation of insulin receptor substrate-1 (IRS-1) is
inhibited by IRS-1 serine phosphorylation. J. Biol. Chem. 274,
27969–27974 (1999).
Article  CAS  PubMed  Google Scholar 
109. Nguyen, H., Ramana, C. V., Bayes, J. & Stark, G. R. Roles of
phosphatidylinositol 3-kinase in interferon-γ-dependent
phosphorylation of STAT1 on serine 727 and activation of
gene expression. J. Biol. Chem. 276, 33361–33368 (2001).
Article  CAS  PubMed  Google Scholar 
110. DeVries, T. A., Rachelle, L., Kalkofen, A., Matassa, A. &
Reyland, M. E. Protein kinase Cδ regulates apoptosis via
activation of STAT1. J. Biol. Chem. 279, 45603–45612 (2004).
Article  CAS  PubMed  Google Scholar 
111. Lu, Z. et al. Tumor promotion by depleting cells of protein
kinase C-δ. Mol. Cell. Biol. 17, 3418–3428 (1997).
Article  CAS  PubMed  PubMed Central  Google Scholar 
112. Redding, P. J. et al. Transgenic mice overexpressing protein
kinase C δ in the epidermis are resistant to skin tumor
promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer
Res. 59, 5710–5718 (1999).
Google Scholar 
113. Srivastava, K. K. et al. Engagement of protein kinase C-θ in
interferon signaling in T-cells. J. Biol. Chem. 279, 29911–
29920 (2004).
Article  CAS  PubMed  Google Scholar 
114. Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-kinase
AKT pathway in human cancer. Nature Rev. Cancer 2, 489–
501 (2002).


Article  CAS  Google Scholar 
115. Barca, O. et al. Interferon β promotes survival in primary
astrocytes through phosphatidylinositol 3-kinase. J.
Neuroimmunol. 139, 155–159 (2003).
Article  CAS  PubMed  Google Scholar 
116. Ruuth, K., Carlsson, L., Hallberg, B. & Lundgren, E.
Interferon-α promotes survival of human primary B-
lymphocytes via phosphatidylinositol 3-kinase. Biochem.
Biophys. Res. Commun. 284, 583–586 (2001).
Article  CAS  PubMed  Google Scholar 
117. Wang, K. et al. Inhibition of neutrophil apoptosis by type 1
IFN depends on cross-talk between phosphoinositol 3-kinase,
protein kinase C-δ, and NF-κB signaling pathways. J.
Immunol. 171, 1035–1041 (2003).
Article  CAS  PubMed  Google Scholar 
118. Yang, C. H. et al. Interferon α/β promotes cell survival by
activating nuclear factor κB through phosphatidylinositol 3-
kinase and Akt. J. Biol. Chem. 276, 13756–13761 (2001).
Article  CAS  PubMed  Google Scholar 
119. Thyrell, L. et al. Interferon α-induced apoptosis in tumor cells
is mediated through the phosphoinositide 3-kinase/
mammalian target of rapamycin signaling pathway. J. Biol.
Chem. 279, 24152–24162 (2004).
Article  CAS  PubMed  Google Scholar 
120. Hwang, S. Y. et al. LY294002 inhibits interferon-γ-stimulated
inducible nitric oxide synthase expression in BV2 microglial
cells. Biochem. Biophys. Res. Commun. 318, 691–697 (2004).
Article  CAS  PubMed  Google Scholar 
121. Navarro, A., Anand-Apte, B., Tanabe, Y., Feldman, G. &


Larner, A. C. A PI-3 kinase-dependent, Stat1-independent
signaling pathway regulates interferon-stimulated monocyte
adhesion. J. Leukoc. Biol. 73, 540–545 (2003).
Article  CAS  PubMed  Google Scholar 
122. Rani, M. R., Hibbert, L., Sizemore, N., Stark, G. R. &
Ransohoff, R. M. Requirement of phosphoinositide 3-kinase
and Akt for interferon-β-mediated induction of the β-R1
(SCYB11) gene. J. Biol. Chem. 277, 38456–38461 (2002).
Article  CAS  PubMed  Google Scholar 
123. Marcus, P. I. & Salb, J. M. Molecular basis of interferon
action: inhibition of viral RNA translation. Virology 30, 502–
516 (1966).
Article  CAS  PubMed  Google Scholar 
124. Doualla-Bell, F. & Koromilas, A. E. Induction of PG G/H
synthase-2 in bovine myometrial cells by interferon-τ requires
the activation of the p38 MAPK pathway. Endocrinology 142,
5107–5115 (2001).
Article  CAS  PubMed  Google Scholar 
125. Lekmine, F. et al. Activation of the p70 S6 kinase and
phosphorylation of the 4E-BP1 repressor of mRNA translation
by type I interferons. J. Biol. Chem. 278, 27772–27780
(2003). The first report that type I IFNs activate pathways
for the initiation of mRNA translation that are
downstream of MTOR.
Article  CAS  PubMed  Google Scholar 
126. Lekmine, F. et al. Interferon-γ engages the p70 S6 kinase to
regulate phosphorylation of the 40S S6 ribosomal protein.
Exp. Cell Res. 295, 173–182 (2004).
Article  CAS  PubMed  Google Scholar 
127. Hay, N. & Sonenberg, N. Upstream and downstream of mTOR.


Genes Dev. 18, 1926–1945 (2004). A comprehensive review
of MTOR and the regulation of signals for mRNA
translation.
Article  CAS  PubMed  Google Scholar 
128. Bjornsti, M. A. & Houghton, P. J. The TOR pathway: a target
for cancer therapy. Nature Rev. Cancer 4, 335–348 (2004).
Article  CAS  Google Scholar 
129. Gingras, A. C. et al. Hierarchical phosphorylation of the
translation inhibitor 4E-BP1. Genes Dev. 15, 2852–2864
(2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
130. Lal, L. et al. Activation of the p70 S6 kinase by all-trans-
retinoic acid in acute promyelocytic leukemia cells. Blood
105, 1669–1677 (2005).
Article  CAS  PubMed  Google Scholar 
131. Garber, K. Rapamycin's resurrection: a new way to target the
cancer cell cycle. J. Natl Cancer Inst. 93, 1517–1519 (2001).
Article  CAS  PubMed  Google Scholar 
132. Ramana, C. V., Gil, P. M., Schreiber, R. D. & Stark, G. R.
Stat1-dependent and -independent pathways in IFNγ-
dependent signaling. Trends Immunol. 23, 96–101 (2002).
Article  CAS  PubMed  Google Scholar 
133. Sizemore, N. et al. Inhibitor of κB kinase is required to
activate a subset of interferon γ-stimulated genes. Proc. Natl
Acad. Sci. USA 101, 7994–7998 (2004).
Article  CAS  PubMed  PubMed Central  Google Scholar 
134. Cantley, L. C. The phosphoinositide 3-kinase pathway. Science
296, 1655–1657 (2002).


Article  CAS  PubMed  Google Scholar 
135. Deane, J. A. & Fruman, D. A. Phosphoinositide 3-kinase:
diverse roles in immune cell activation. Annu. Rev. Immunol.
22, 563–598 (2004).
Article  CAS  PubMed  Google Scholar 
136. Malik, A. H. & Lee, W. M. Chronic hepatitis B virus infection:
treatment strategies for the next millennium. Ann. Intern.
Med. 132, 723–731 (2000).
Article  CAS  PubMed  Google Scholar 
137. Liang, T. J., Rehermann, B., Seeff, L. B. & Hoofnagle, J. H.
Pathogenesis, natural history, treatment, and prevention of
hepatitis C. Ann. Intern. Med. 132, 296–305 (2000).
Article  CAS  PubMed  Google Scholar 
138. Loutfy, M. R. et al. Interferon alfacon-1 plus corticosteroids in
severe acute respiratory syndrome: a preliminary study.
JAMA 290, 3222–3228 (2003).
Article  CAS  PubMed  Google Scholar 
Download references
Author information
Authors and Affiliations
1. Robert H. Lurie Comprehensive Cancer Center, Northwestern
University Medical School, 710 North Fairbanks Court, Olson
8250, Chicago, 60611, Illinois, USA
Leonidas C. Platanias
Authors


1. Leonidas C. Platanias
View author publications
Search author on:PubMed Google Scholar
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
Related links
DATABASES
Entrez Gene
CRKL
IFN-α
IFN-β
IFN-γ
IFN-ε
IFN-κ
IFN-ω
IFNAR1
IFNAR2
IFNGR1


IFNGR2
IRF9
JAK1
JAK2
p38
p85
p110
STAT1
STAT2
STAT5
TYK2
Glossary
HISTONE ACETYLTRANSFERASE
A protein that acetylates core histones, which results in
important regulatory effects on chromatin structure and
assembly, and on gene transcription.
VIRAL CRK
(vCRK). The product of an oncogene encoded by the CT10
avian sarcoma virus. The oncogene transforms cells and can
induce tumours in newborn chickens.
SRC-HOMOLOGY-2 DOMAINS
(SH2 domains). Protein domains that are commonly found
in signal-transduction molecules. They specifically interact
with phosphotyrosine-containing protein sequences.


SH3 DOMAINS
(SRC-homology-3 domains). Protein domains that are
commonly found in signal-transduction molecules. They
specifically interact with certain proline-containing protein
sequences. Classically, they contain either (Arg/Lys)-X-X-
Pro-X-X-Pro or Pro-X-X-Pro-X-Arg motifs, where X denotes
any amino acid.
GUANINE-NUCLEOTIDE-EXCHANGE FACTORS
Proteins that stimulate the exchange of guanine
diphosphate (GDP) for guanine triphoshate (GTP) in small
GTPases, resulting in activation of the GTPase.
BCR–ABL ONCOGENE
A fusion gene that results from an abnormal chromosomal
translocation in which the breakpoint-cluster region (BCR)
is fused to the Abelson leukaemia virus (ABL) tyrosine-
kinase gene. In humans, this oncogene is involved in the
pathogenesis of chronic myeloid leukaemia and some cases
of acute lymphoblastic leukaemia.
CAP-DEPENDENT TRANSLATION
An important step for the initiation of mRNA translation. It
involves a complex process in which the Met-tRNAi
initiator and the 40S and 60S ribosomal subunits are all
assembled by eukaryotic translation-initiation factors into
the 80S ribosome at the start codon of a specific mRNA.
PLECKSTRIN-HOMOLOGY DOMAINS
Amino-acid sequences that are present in several signalling
proteins that mediate their function through binding
phosphatidylinositols. A subset of these domains selectively
binds phosphatidylinositol 3-kinase products. Pleckstrin-
homology domains also anchor proteins to membranes by
binding membrane lipids.
PHOX-HOMOLOGY DOMAINS


Amino-acid sequences that are present in certain signalling
proteins and that target these proteins to organelle
membranes. Such targeting occurs through interactions
between conserved motifs in the PHOX-homology domains
and specific phosphoinositides. These domains have a
structure that is distinct from pleckstrin-homology domains.
Rights and permissions
Reprints and permissions
About this article
Cite this article
Platanias, L. Mechanisms of type-I- and type-II-interferon-mediated
signalling. Nat Rev Immunol 5, 375–386 (2005). https://
doi.org/10.1038/nri1604
Download citation
•  Issue date: 01 May 2005
•  DOI: https://doi.org/10.1038/nri1604
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative


This article is cited by
•  FLT3L-induced virtual memory CD8 T cells
engage the immune system against tumors
○  Hsin-Fang Tu
○  Yu-Jui Kung
○  Chien-Fu Hung
Journal of Biomedical Science (2024)
•  High efficacy of huCD20-targeted AcTaferon in
humanized patient derived xenograft models of
aggressive B cell lymphoma
○  Willem Daneels
○  Alexander Van Parys
○  Fritz Offner
Experimental Hematology & Oncology (2024)
•  Potential role of RhoA GTPase regulation in type
interferon signaling in systemic lupus
erythematosus
○  Wei Fan
○  Bo Wei
○  Richard Bucala
Arthritis Research & Therapy (2024)
•  FOXP3+ regulatory T cell perturbation mediated
by the IFNγ-STAT1-IFITM3 feedback loop is
essential for anti-tumor immunity
○  Xinnan Liu
○  Weiqi Zhang


○  Bin Li
Nature Communications (2024)
•  A co-formulation of interferons alpha2b and
gamma distinctively targets cell cycle in the
glioblastoma-derived cell line U-87MG
○  Jamilet Miranda
○  Dania Vázquez-Blomquist
○  Iraldo Bello-Rivero
BMC Cancer (2023)
 Access through your institution
Buy or subscribe
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Videos
•  Current issue
•  Collections
•  Follow us on Facebook
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed


About the journal
•  Aims & Scope
•  Journal Information
•  Editorial policies
•  About the Editors
•  Reviews Cross-Journal Editorial Team
•  Journal Credits
•  Editorial input and checks
•  Editorial Values Statement
•  Journal Metrics
•  Publishing model
•  Calendars
•  Conferences
•  Posters
•  Web Feeds
•  Contact
Publish with us
•  For Authors
•  For Referees
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job


•  Guide to authors
•  Editorial policies
Nature Reviews Immunology (Nat Rev Immunol)
ISSN 1474-1741 (online)
ISSN 1474-1733 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions


Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


 Close
[image]
Sign up for the Nature Briefing newsletter — what matters in
science, free to your inbox daily.
Email address


Sign up
I agree my information will be processed in accordance with the
Nature and Springer Nature Limited Privacy Policy.
 Close
Get the most important science stories of the day, free in your
inbox. Sign up for Nature Briefing
[image]


